Deal snapshot: Alliance Pharma to Acquire Drug Development Solutions Business of UK-Based LGC.

MANews-(C)2009-2022

US-based bioanalytical a contract research organisation (CRO) Alliance Pharma has agreed to acquire UK-based Drug Development Solutions (DDS), the bioanalytical business unit of life science tools company LGC, the company said.

Terms of the transaction were not disclosed. US-based investment...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT